<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03933618</url>
  </required_header>
  <id_info>
    <org_study_id>4134</org_study_id>
    <nct_id>NCT03933618</nct_id>
  </id_info>
  <brief_title>Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function</brief_title>
  <acronym>CAP</acronym>
  <official_title>A Randomized Double Blinded Placebo Controlled Trial Between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile Function Using ADAM, IIEF and EHS Validated Scales</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratory Corporation of America</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Albany Medical College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates anastrazole and clomiphene in the improvement in hypogonadal symptoms
      and erectile function. Each subject will receive Anastrazole 1 mg/day, clomiphene 25 mg/day
      and placebo in randomized schedule of 8 week intervals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aromatase inhibitors (AI) (Anastrazole) and selective estrogen receptor modifiers
      (SERMS)(clomiphene) increase testosterone production through stimulation of the hypothalamic
      pituitary axis. While these drugs both reduce the feedback inhibition of estrogen on the
      pituitary, SERMs cause an increase in serum estradiol, whereas AIs reduce estradiol levels.
      Using these medications, we can obtain therapeutic testosterone levels with either an
      increase or decrease in estradiol levels.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2015</start_date>
  <completion_date type="Actual">March 8, 2017</completion_date>
  <primary_completion_date type="Actual">March 8, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IIEF (International Index of Erectile Function) Score - Screen</measure>
    <time_frame>At baseline</time_frame>
    <description>15 item self reported erectile function. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IIEF (International Index of Erectile Function) Score - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IIEF (International Index of Erectile Function) Score - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IIEF (International Index of Erectile Function) Score - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Normalized Testosterone - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Normalized at &gt;350ng/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normalized Testosterone - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Normalized at &gt;350ng/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normalized Testosterone - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Normalized at &gt;350ng/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normalized Testosterone - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Normalized at &gt;350ng/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADAM (Androgen Deficiency in the Aging Male) Score - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADAM (Androgen Deficiency in the Aging Male) Score - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADAM (Androgen Deficiency in the Aging Male) Score - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADAM (Androgen Deficiency in the Aging Male) Score - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EHS (Erectile Hardness Score) - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EHS (Erectile Hardness Score) - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EHS (Erectile Hardness Score) - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EHS (Erectile Hardness Score) - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LH - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LH - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LH - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LH - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FSH - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Lab Values for follicle stimulating hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FSH - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Lab Values for follicle stimulating hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FSH - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Lab Values for follicle stimulating hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FSH - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Lab Values for follicle stimulating hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free Testosterone - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Measure of Free Testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free Testosterone - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Measure of Free Testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free Testosterone - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Measure of Free Testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free Testosterone - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Measure of Free Testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estradiol - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estradiol - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estradiol - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estradiol - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SHBG - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SHBG - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SHBG - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SHBG - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SEP #1-3 Cumulative - Screen</measure>
    <time_frame>Baseline</time_frame>
    <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SEP #1-3 Cumulative - Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SEP #1-3 Cumulative - Week 16</measure>
    <time_frame>Week 16</time_frame>
    <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SEP #1-3 Cumulative - Week 24</measure>
    <time_frame>Week 24</time_frame>
    <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Hypogonadism, Male</condition>
  <arm_group>
    <arm_group_label>anastrazole-clomiphene-placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>anastrazole-placebo-clomiphene</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clomiphene-anastrazole-placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clomiphene-placebo-anastrazole</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo-clomiphene-anastrazole</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo-anastrazole-clomiphene</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anastrozole 1mg</intervention_name>
    <arm_group_label>anastrazole-clomiphene-placebo</arm_group_label>
    <arm_group_label>anastrazole-placebo-clomiphene</arm_group_label>
    <arm_group_label>clomiphene-anastrazole-placebo</arm_group_label>
    <arm_group_label>clomiphene-placebo-anastrazole</arm_group_label>
    <arm_group_label>placebo-anastrazole-clomiphene</arm_group_label>
    <arm_group_label>placebo-clomiphene-anastrazole</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene Citrate 25mg</intervention_name>
    <arm_group_label>anastrazole-clomiphene-placebo</arm_group_label>
    <arm_group_label>anastrazole-placebo-clomiphene</arm_group_label>
    <arm_group_label>clomiphene-anastrazole-placebo</arm_group_label>
    <arm_group_label>clomiphene-placebo-anastrazole</arm_group_label>
    <arm_group_label>placebo-anastrazole-clomiphene</arm_group_label>
    <arm_group_label>placebo-clomiphene-anastrazole</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo - Cap</intervention_name>
    <arm_group_label>anastrazole-clomiphene-placebo</arm_group_label>
    <arm_group_label>anastrazole-placebo-clomiphene</arm_group_label>
    <arm_group_label>clomiphene-anastrazole-placebo</arm_group_label>
    <arm_group_label>clomiphene-placebo-anastrazole</arm_group_label>
    <arm_group_label>placebo-anastrazole-clomiphene</arm_group_label>
    <arm_group_label>placebo-clomiphene-anastrazole</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men age 18-70

          2. Baseline morning Testosterone 150-350 ng/dL x2

          3. leutenizing hormone (LH) 1.5-9.2 miU/mL, Follicle stimulation hormone (FSH) 1.6-8.0
             miU/mL, Prolactin 4-15 ng/mL

          4. Positive Androgen Deficiency in the Aging Male (ADAM) score. A positive score is when
             an affirmative answer (''yes'') to either questions &quot;Do you have a decreased sex
             drive/libido?&quot; or &quot;Are your erections less strong?&quot; or any three other questions.10

          5. Body mass index (BMI) &lt;40

          6. Sexual health inventory for men (SHIM) score &gt;7 and &lt;21. Patients are allowed to be
             taking phosphodiesterase 5 inhibitors (i.e. Viagra, Levitra, Cialis) at baseline,
             however we will ask them to do the SHIM survey as if they were not taking this
             medication.

          7. Men must attempt to have at least four sexual encounters over each of the eight-week
             periods

          8. Men willing not to take phosphodiesterase 5 inhibitors throughout the entire study

        Exclusion Criteria:

          1. Current or previous history of prostate cancer

          2. Previous or current androgen deprivation therapy for prostate cancer,

          3. Past surgical history of prostatectomy.

          4. History of testicular cancer.

          5. History of deep vein thrombosis (DVT) or blood dyscrasia

          6. History of breast cancer

          7. Men with past or current treatment for erectile dysfunction including MUSE
             (alprostodil), intracavernosal injections, penile prosthesis. Men not on treatment or
             men who are on phosphodiesterase inhibitors will be allowed to be in the study but
             must stop their use at the screening visit.

          8. Chronic opioid use

          9. Use of steroids within the past 3 months, including prednisone and/or cortisone
             injections, and inhaled steroids. Topical steroid cream is acceptable.

         10. History of or current use of anabolic steroids, i.e. testosterone, (or any analog of
             testosterone) dihydroepiandrosterone (DHEA), dihydroepiandrosterone sulfate (DHEAS) or
             any growth promoters i.e. growth hormone itself or analogs of growth hormone

         11. History of or current use of anti-androgen medications, i.e. Aldactone, Tagamet,
             estrogens

         12. Alcohol intake &gt; 30 grams (drink more than 2 beers per day OR more than 1 glass of
             wine or cocktail daily)

         13. Having started a new medication during the past three months which may interfere with
             the outcome measures of the study

         14. Polycythemia (HCT &gt;52% )

         15. History of prostate specific antigen (PSA)&gt; 4.0 ng/dl

         16. Hematocrit (HCT)&lt; 36 %

         17. Liver function tests greater than 2 times upper normal limits or history of abnormal
             electrolytes, calcium or Parathyroid hormone without workup, at the discretion of the
             investigator.

         18. Previous hypogonadal treatment within last 3 months. -
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert C Welliver, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albany Medical College</affiliation>
  </overall_official>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>April 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2019</study_first_posted>
  <results_first_submitted>July 15, 2019</results_first_submitted>
  <results_first_submitted_qc>October 26, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 18, 2019</results_first_posted>
  <last_update_submitted>October 26, 2019</last_update_submitted>
  <last_update_submitted_qc>October 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypogonadism</mesh_term>
    <mesh_term>Eunuchism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anastrozole</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 18, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT03933618/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Men will be incentivized to come to each clinic appointment with $20 dollars at the end. If they complete the study they will be able to earn $100. Men will be incentivized to not use phosphodiesterase inhibitors throughout the study by giving them three 100mg tablets of Viagra per month of the study for a total of twelve 100 mg tablets.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Anastrazole-clomiphene-placebo</title>
          <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="P2">
          <title>Anastrazole-placebo-clomiphene</title>
          <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="P3">
          <title>Clomiphene-anastrazole-placebo</title>
          <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="P4">
          <title>Clomiphene-placebo-anastrazole</title>
          <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="P5">
          <title>Placebo-clomiphene-anastrazole</title>
          <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="P6">
          <title>Placebo-anastrazole-clomiphene</title>
          <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Baseline to Week 8</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Week 8 to Week 16</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Week 16 to Week 24</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Anastrazole-clomiphene-placebo</title>
          <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="B2">
          <title>Anastrazole-placebo-clomiphene</title>
          <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="B3">
          <title>Clomiphene-anastrazole-placebo</title>
          <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="B4">
          <title>Clomiphene-placebo-anastrazole</title>
          <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="B5">
          <title>Placebo-clomiphene-anastrazole</title>
          <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="B6">
          <title>Placebo-anastrazole-clomiphene</title>
          <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="4"/>
            <count group_id="B4" value="4"/>
            <count group_id="B5" value="4"/>
            <count group_id="B6" value="4"/>
            <count group_id="B7" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>IIEF (International Index of Erectile Function) Score - Screen</title>
        <description>15 item self reported erectile function. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
        <time_frame>At baseline</time_frame>
        <population>Total IIEF reported at the initial encounter.</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>IIEF (International Index of Erectile Function) Score - Screen</title>
          <description>15 item self reported erectile function. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
          <population>Total IIEF reported at the initial encounter.</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="43"/>
                    <measurement group_id="O3" value="57"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="57"/>
                    <measurement group_id="O6" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="45"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="36"/>
                    <measurement group_id="O6" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="58"/>
                    <measurement group_id="O6" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="55"/>
                    <measurement group_id="O4" value="47"/>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>IIEF (International Index of Erectile Function) Score - Week 8</title>
        <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
        <time_frame>Week 8</time_frame>
        <population>Total IIEF reported at the end of the first 8 week period</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>IIEF (International Index of Erectile Function) Score - Week 8</title>
          <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
          <population>Total IIEF reported at the end of the first 8 week period</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="66"/>
                    <measurement group_id="O6" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="63"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="72"/>
                    <measurement group_id="O6" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="65"/>
                    <measurement group_id="O5" value="43"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="65"/>
                    <measurement group_id="O3" value="70"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>IIEF (International Index of Erectile Function) Score - Week 16</title>
        <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
        <time_frame>Week 16</time_frame>
        <population>Total IIEF reported at the end of the second 8 week period - at week 16
Data for patient 23 was not collected in the placebo-clomiphene-anastrazole arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>IIEF (International Index of Erectile Function) Score - Week 16</title>
          <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
          <population>Total IIEF reported at the end of the second 8 week period - at week 16
Data for patient 23 was not collected in the placebo-clomiphene-anastrazole arm.</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="66"/>
                    <measurement group_id="O6" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="55"/>
                    <measurement group_id="O5" value="33"/>
                    <measurement group_id="O6" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="62"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="58"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="51"/>
                    <measurement group_id="O4" value="47"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>IIEF (International Index of Erectile Function) Score - Week 24</title>
        <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
        <time_frame>Week 24</time_frame>
        <population>Total IIEF reported at the end of the final 8 week period - at week 24
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>IIEF (International Index of Erectile Function) Score - Week 24</title>
          <description>15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75</description>
          <population>Total IIEF reported at the end of the final 8 week period - at week 24
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="70"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="52"/>
                    <measurement group_id="O5" value="65"/>
                    <measurement group_id="O6" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="60"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="35"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                    <measurement group_id="O2" value="65"/>
                    <measurement group_id="O4" value="72"/>
                    <measurement group_id="O5" value="45"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="60"/>
                    <measurement group_id="O4" value="47"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Normalized Testosterone - Screen</title>
        <description>Normalized at &gt;350ng/dl</description>
        <time_frame>Baseline</time_frame>
        <population>Normalized Testosterone measured week 0 - initial screen
Data not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Normalized Testosterone - Screen</title>
          <description>Normalized at &gt;350ng/dl</description>
          <population>Normalized Testosterone measured week 0 - initial screen
Data not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="205"/>
                    <measurement group_id="O2" value="330"/>
                    <measurement group_id="O3" value="226"/>
                    <measurement group_id="O4" value="367"/>
                    <measurement group_id="O5" value="315"/>
                    <measurement group_id="O6" value="321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="293"/>
                    <measurement group_id="O2" value="237"/>
                    <measurement group_id="O3" value="194"/>
                    <measurement group_id="O4" value="300"/>
                    <measurement group_id="O5" value="214"/>
                    <measurement group_id="O6" value="243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="347"/>
                    <measurement group_id="O2" value="328"/>
                    <measurement group_id="O3" value="268"/>
                    <measurement group_id="O4" value="206"/>
                    <measurement group_id="O5" value="321"/>
                    <measurement group_id="O6" value="148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95"/>
                    <measurement group_id="O2" value="291"/>
                    <measurement group_id="O3" value="306"/>
                    <measurement group_id="O4" value="244"/>
                    <measurement group_id="O6" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Normalized Testosterone - Week 8</title>
        <description>Normalized at &gt;350ng/dl</description>
        <time_frame>Week 8</time_frame>
        <population>Normalized Testosterone measured at the end of the first 8 week period
Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Normalized Testosterone - Week 8</title>
          <description>Normalized at &gt;350ng/dl</description>
          <population>Normalized Testosterone measured at the end of the first 8 week period
Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="484"/>
                    <measurement group_id="O2" value="757"/>
                    <measurement group_id="O3" value="566"/>
                    <measurement group_id="O4" value="1316"/>
                    <measurement group_id="O5" value="133"/>
                    <measurement group_id="O6" value="470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="387"/>
                    <measurement group_id="O2" value="296"/>
                    <measurement group_id="O3" value="693"/>
                    <measurement group_id="O4" value="917"/>
                    <measurement group_id="O5" value="271"/>
                    <measurement group_id="O6" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="607"/>
                    <measurement group_id="O2" value="453"/>
                    <measurement group_id="O3" value="216"/>
                    <measurement group_id="O4" value="527"/>
                    <measurement group_id="O5" value="270"/>
                    <measurement group_id="O6" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="545"/>
                    <measurement group_id="O2" value="676"/>
                    <measurement group_id="O3" value="592"/>
                    <measurement group_id="O4" value="497"/>
                    <measurement group_id="O6" value="296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Normalized Testosterone - Week 16</title>
        <description>Normalized at &gt;350ng/dl</description>
        <time_frame>Week 16</time_frame>
        <population>Normalized Testosterone measured at the end of the 16th week
Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Normalized Testosterone - Week 16</title>
          <description>Normalized at &gt;350ng/dl</description>
          <population>Normalized Testosterone measured at the end of the 16th week
Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="437"/>
                    <measurement group_id="O2" value="591"/>
                    <measurement group_id="O3" value="338"/>
                    <measurement group_id="O4" value="391"/>
                    <measurement group_id="O5" value="696"/>
                    <measurement group_id="O6" value="502"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="337"/>
                    <measurement group_id="O2" value="200"/>
                    <measurement group_id="O3" value="451"/>
                    <measurement group_id="O4" value="403"/>
                    <measurement group_id="O5" value="396"/>
                    <measurement group_id="O6" value="520"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="329"/>
                    <measurement group_id="O2" value="191"/>
                    <measurement group_id="O3" value="124"/>
                    <measurement group_id="O4" value="206"/>
                    <measurement group_id="O5" value="585"/>
                    <measurement group_id="O6" value="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="609"/>
                    <measurement group_id="O2" value="323"/>
                    <measurement group_id="O3" value="456"/>
                    <measurement group_id="O4" value="288"/>
                    <measurement group_id="O6" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Normalized Testosterone - Week 24</title>
        <description>Normalized at &gt;350ng/dl</description>
        <time_frame>Week 24</time_frame>
        <population>Normalized Testosterone measured at the end of the 24th week
Data was not collected for patient 15 clomiphene-anastrazole-placebo Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Normalized Testosterone - Week 24</title>
          <description>Normalized at &gt;350ng/dl</description>
          <population>Normalized Testosterone measured at the end of the 24th week
Data was not collected for patient 15 clomiphene-anastrazole-placebo Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="268"/>
                    <measurement group_id="O2" value="793"/>
                    <measurement group_id="O3" value="214"/>
                    <measurement group_id="O4" value="537"/>
                    <measurement group_id="O5" value="412"/>
                    <measurement group_id="O6" value="596"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="269"/>
                    <measurement group_id="O2" value="519"/>
                    <measurement group_id="O3" value="440"/>
                    <measurement group_id="O4" value="531"/>
                    <measurement group_id="O5" value="375"/>
                    <measurement group_id="O6" value="972"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="446"/>
                    <measurement group_id="O2" value="449"/>
                    <measurement group_id="O4" value="447"/>
                    <measurement group_id="O5" value="487"/>
                    <measurement group_id="O6" value="195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="196"/>
                    <measurement group_id="O2" value="630"/>
                    <measurement group_id="O3" value="274"/>
                    <measurement group_id="O4" value="486"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ADAM (Androgen Deficiency in the Aging Male) Score - Screen</title>
        <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
        <time_frame>Baseline</time_frame>
        <population>Initial Evaluation for ADAM score - Week 0</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>ADAM (Androgen Deficiency in the Aging Male) Score - Screen</title>
          <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
          <population>Initial Evaluation for ADAM score - Week 0</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ADAM (Androgen Deficiency in the Aging Male) Score - Week 8</title>
        <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
        <time_frame>Week 8</time_frame>
        <population>ADAM score at the end of Week 8
Data was not collected for patient 19 in anastrazole-clomiphene-placebo arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>ADAM (Androgen Deficiency in the Aging Male) Score - Week 8</title>
          <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
          <population>ADAM score at the end of Week 8
Data was not collected for patient 19 in anastrazole-clomiphene-placebo arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ADAM (Androgen Deficiency in the Aging Male) Score - Week 16</title>
        <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
        <time_frame>Week 16</time_frame>
        <population>ADAM score at the end of Week 16 Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>ADAM (Androgen Deficiency in the Aging Male) Score - Week 16</title>
          <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
          <population>ADAM score at the end of Week 16 Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ADAM (Androgen Deficiency in the Aging Male) Score - Week 24</title>
        <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
        <time_frame>Week 24</time_frame>
        <population>ADAM score at the end of Week 24 No data collected pt 15 in clomiphene-anastrazole-placebo arm no data collected for pt 16 clomiphene-placebo-anastrazole arm no data collected for pt 23 placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>ADAM (Androgen Deficiency in the Aging Male) Score - Week 24</title>
          <description>Self reported quantification of hypogonadism. 10 &quot;yes&quot; or &quot;no&quot; questions.
A positive (yes) questionnaire result is defined as a &quot;yes or 1&quot; and a negative (no) questionnaire result is defined as a &quot;no or 0&quot; to question 1 or question 7 or any 3 other questions.
Yes (1) represents a better outcome than No (1)
In Data Entry:
Yes - 1 No - 0</description>
          <population>ADAM score at the end of Week 24 No data collected pt 15 in clomiphene-anastrazole-placebo arm no data collected for pt 16 clomiphene-placebo-anastrazole arm no data collected for pt 23 placebo-clomiphene-anastrazole arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>EHS (Erectile Hardness Score) - Screen</title>
        <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
        <time_frame>Baseline</time_frame>
        <population>Score 0-4 at the initial encounter week 0</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>EHS (Erectile Hardness Score) - Screen</title>
          <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
          <population>Score 0-4 at the initial encounter week 0</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>EHS (Erectile Hardness Score) - Week 8</title>
        <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
        <time_frame>Week 8</time_frame>
        <population>Score 0-4 at the end of Week 8</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>EHS (Erectile Hardness Score) - Week 8</title>
          <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
          <population>Score 0-4 at the end of Week 8</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>EHS (Erectile Hardness Score) - Week 16</title>
        <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
        <time_frame>Week 16</time_frame>
        <population>Score 0-4 at the end of Week 16
Data for patient 23 was not collected in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>EHS (Erectile Hardness Score) - Week 16</title>
          <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
          <population>Score 0-4 at the end of Week 16
Data for patient 23 was not collected in placebo-clomiphene-anastrazole arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>EHS (Erectile Hardness Score) - Week 24</title>
        <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
        <time_frame>Week 24</time_frame>
        <population>Score 0-4 at the end of Week 24 no data was collected for patient 15 in clomiphene-anastrazole-placebo no data was collected for patient 23 in placebo-clomiphene-anastrazole</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>EHS (Erectile Hardness Score) - Week 24</title>
          <description>Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid</description>
          <population>Score 0-4 at the end of Week 24 no data was collected for patient 15 in clomiphene-anastrazole-placebo no data was collected for patient 23 in placebo-clomiphene-anastrazole</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LH - Screen</title>
        <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
        <time_frame>Baseline</time_frame>
        <population>LH measured at initial encounter
Data for pt 23 in placebo-clomiphene-anastrazole not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>LH - Screen</title>
          <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
          <population>LH measured at initial encounter
Data for pt 23 in placebo-clomiphene-anastrazole not collected</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5"/>
                    <measurement group_id="O2" value="3.6"/>
                    <measurement group_id="O3" value="3.8"/>
                    <measurement group_id="O4" value="6.8"/>
                    <measurement group_id="O5" value="3.5"/>
                    <measurement group_id="O6" value="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4"/>
                    <measurement group_id="O2" value="3.8"/>
                    <measurement group_id="O3" value="2.4"/>
                    <measurement group_id="O4" value="4.1"/>
                    <measurement group_id="O5" value="2.4"/>
                    <measurement group_id="O6" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                    <measurement group_id="O2" value="3.5"/>
                    <measurement group_id="O3" value="4.1"/>
                    <measurement group_id="O4" value="3.3"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3"/>
                    <measurement group_id="O2" value="4.1"/>
                    <measurement group_id="O3" value="4.7"/>
                    <measurement group_id="O4" value="5.9"/>
                    <measurement group_id="O6" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LH - Week 8</title>
        <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
        <time_frame>Week 8</time_frame>
        <population>LH measured at week 8
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>LH - Week 8</title>
          <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
          <population>LH measured at week 8
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1"/>
                    <measurement group_id="O2" value="5.1"/>
                    <measurement group_id="O3" value="9.9"/>
                    <measurement group_id="O4" value="17.3"/>
                    <measurement group_id="O5" value="3.6"/>
                    <measurement group_id="O6" value="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="10.7"/>
                    <measurement group_id="O4" value="12.6"/>
                    <measurement group_id="O5" value="3.3"/>
                    <measurement group_id="O6" value="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9"/>
                    <measurement group_id="O2" value="6.9"/>
                    <measurement group_id="O3" value="6.1"/>
                    <measurement group_id="O4" value="4.7"/>
                    <measurement group_id="O5" value="6.7"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2"/>
                    <measurement group_id="O2" value="11.5"/>
                    <measurement group_id="O3" value="7.5"/>
                    <measurement group_id="O4" value="6.9"/>
                    <measurement group_id="O6" value="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LH - Week 16</title>
        <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
        <time_frame>Week 16</time_frame>
        <population>LH measured at week 16
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>LH - Week 16</title>
          <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
          <population>LH measured at week 16
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8"/>
                    <measurement group_id="O2" value="4.6"/>
                    <measurement group_id="O3" value="4.2"/>
                    <measurement group_id="O4" value="5.4"/>
                    <measurement group_id="O5" value="13.9"/>
                    <measurement group_id="O6" value="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9"/>
                    <measurement group_id="O2" value="4.8"/>
                    <measurement group_id="O3" value="6.3"/>
                    <measurement group_id="O4" value="4.9"/>
                    <measurement group_id="O5" value="5.2"/>
                    <measurement group_id="O6" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9"/>
                    <measurement group_id="O2" value="2.1"/>
                    <measurement group_id="O3" value="2.2"/>
                    <measurement group_id="O4" value="1.9"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8"/>
                    <measurement group_id="O2" value="4.3"/>
                    <measurement group_id="O3" value="6.6"/>
                    <measurement group_id="O4" value="4.9"/>
                    <measurement group_id="O6" value="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LH - Week 24</title>
        <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
        <time_frame>Week 24</time_frame>
        <population>LH measured at week 24
No data for patient 13 collected in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>LH - Week 24</title>
          <description>Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.</description>
          <population>LH measured at week 24
No data for patient 13 collected in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4.1"/>
                    <measurement group_id="O3" value="3.4"/>
                    <measurement group_id="O4" value="6.4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1"/>
                    <measurement group_id="O2" value="12.6"/>
                    <measurement group_id="O3" value="5.9"/>
                    <measurement group_id="O4" value="6.4"/>
                    <measurement group_id="O5" value="2.9"/>
                    <measurement group_id="O6" value="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                    <measurement group_id="O2" value="5.4"/>
                    <measurement group_id="O4" value="7.6"/>
                    <measurement group_id="O5" value="7.1"/>
                    <measurement group_id="O6" value="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7"/>
                    <measurement group_id="O2" value="15.1"/>
                    <measurement group_id="O3" value="4.7"/>
                    <measurement group_id="O4" value="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FSH - Screen</title>
        <description>Lab Values for follicle stimulating hormone</description>
        <time_frame>Baseline</time_frame>
        <population>FSH measured at initial encounter
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>FSH - Screen</title>
          <description>Lab Values for follicle stimulating hormone</description>
          <population>FSH measured at initial encounter
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7"/>
                    <measurement group_id="O2" value="2.4"/>
                    <measurement group_id="O3" value="5.5"/>
                    <measurement group_id="O4" value="4.5"/>
                    <measurement group_id="O5" value="3.3"/>
                    <measurement group_id="O6" value="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7"/>
                    <measurement group_id="O2" value="3.7"/>
                    <measurement group_id="O3" value="3.9"/>
                    <measurement group_id="O4" value="2.9"/>
                    <measurement group_id="O5" value="1.8"/>
                    <measurement group_id="O6" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6"/>
                    <measurement group_id="O2" value="5.1"/>
                    <measurement group_id="O3" value="1.7"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="4.4"/>
                    <measurement group_id="O6" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="4.5"/>
                    <measurement group_id="O4" value="4.4"/>
                    <measurement group_id="O6" value="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FSH - Week 8</title>
        <description>Lab Values for follicle stimulating hormone</description>
        <time_frame>Week 8</time_frame>
        <population>FSH measured at Week 8
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>FSH - Week 8</title>
          <description>Lab Values for follicle stimulating hormone</description>
          <population>FSH measured at Week 8
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4"/>
                    <measurement group_id="O2" value="4.3"/>
                    <measurement group_id="O3" value="8.2"/>
                    <measurement group_id="O4" value="16.2"/>
                    <measurement group_id="O5" value="3.4"/>
                    <measurement group_id="O6" value="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7"/>
                    <measurement group_id="O2" value="6.2"/>
                    <measurement group_id="O3" value="7.8"/>
                    <measurement group_id="O4" value="3.03"/>
                    <measurement group_id="O5" value="2.2"/>
                    <measurement group_id="O6" value="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="8.3"/>
                    <measurement group_id="O3" value="1.8"/>
                    <measurement group_id="O4" value="6.3"/>
                    <measurement group_id="O5" value="4.7"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3"/>
                    <measurement group_id="O2" value="20.3"/>
                    <measurement group_id="O3" value="6.1"/>
                    <measurement group_id="O4" value="8.1"/>
                    <measurement group_id="O6" value="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FSH - Week 16</title>
        <description>Lab Values for follicle stimulating hormone</description>
        <time_frame>Week 16</time_frame>
        <population>FSH measured at Week 16
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>FSH - Week 16</title>
          <description>Lab Values for follicle stimulating hormone</description>
          <population>FSH measured at Week 16
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4.3"/>
                    <measurement group_id="O3" value="4.2"/>
                    <measurement group_id="O4" value="5.3"/>
                    <measurement group_id="O5" value="10.7"/>
                    <measurement group_id="O6" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2"/>
                    <measurement group_id="O2" value="3.7"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="2.9"/>
                    <measurement group_id="O5" value="2.6"/>
                    <measurement group_id="O6" value="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9"/>
                    <measurement group_id="O2" value="3.8"/>
                    <measurement group_id="O3" value="1.2"/>
                    <measurement group_id="O4" value="3.3"/>
                    <measurement group_id="O5" value="8.3"/>
                    <measurement group_id="O6" value="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8"/>
                    <measurement group_id="O2" value="11.4"/>
                    <measurement group_id="O3" value="6.2"/>
                    <measurement group_id="O4" value="4.2"/>
                    <measurement group_id="O6" value="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FSH - Week 24</title>
        <description>Lab Values for follicle stimulating hormone</description>
        <time_frame>Week 24</time_frame>
        <population>FSH measured at Week 24 Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>FSH - Week 24</title>
          <description>Lab Values for follicle stimulating hormone</description>
          <population>FSH measured at Week 24 Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
          <units>IU/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1"/>
                    <measurement group_id="O2" value="4.8"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="5.2"/>
                    <measurement group_id="O5" value="6.5"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4"/>
                    <measurement group_id="O2" value="15.1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="3.7"/>
                    <measurement group_id="O5" value="5.2"/>
                    <measurement group_id="O6" value="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7.2"/>
                    <measurement group_id="O4" value="7.2"/>
                    <measurement group_id="O5" value="5.9"/>
                    <measurement group_id="O6" value="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8"/>
                    <measurement group_id="O2" value="29.7"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Free Testosterone - Screen</title>
        <description>Measure of Free Testosterone</description>
        <time_frame>Baseline</time_frame>
        <population>FT measured at initial encounter
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Free Testosterone - Screen</title>
          <description>Measure of Free Testosterone</description>
          <population>FT measured at initial encounter
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4"/>
                    <measurement group_id="O2" value="6.99"/>
                    <measurement group_id="O3" value="7.28"/>
                    <measurement group_id="O4" value="8.82"/>
                    <measurement group_id="O5" value="6.27"/>
                    <measurement group_id="O6" value="7.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.74"/>
                    <measurement group_id="O2" value="9.31"/>
                    <measurement group_id="O3" value="6.07"/>
                    <measurement group_id="O4" value="9.9"/>
                    <measurement group_id="O5" value="5.82"/>
                    <measurement group_id="O6" value="5.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.56"/>
                    <measurement group_id="O2" value="12.27"/>
                    <measurement group_id="O4" value="4.86"/>
                    <measurement group_id="O5" value="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.19"/>
                    <measurement group_id="O2" value="7.27"/>
                    <measurement group_id="O3" value="6.52"/>
                    <measurement group_id="O4" value="7.71"/>
                    <measurement group_id="O6" value="6.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Free Testosterone - Week 8</title>
        <description>Measure of Free Testosterone</description>
        <time_frame>Week 8</time_frame>
        <population>FT measured at the end of Week 8 Data was not collected for patient 8 in anastrazole-placebo-clomiphene arm Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Free Testosterone - Week 8</title>
          <description>Measure of Free Testosterone</description>
          <population>FT measured at the end of Week 8 Data was not collected for patient 8 in anastrazole-placebo-clomiphene arm Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.46"/>
                    <measurement group_id="O2" value="21.8"/>
                    <measurement group_id="O3" value="17.72"/>
                    <measurement group_id="O4" value="35.27"/>
                    <measurement group_id="O5" value="2.71"/>
                    <measurement group_id="O6" value="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.63"/>
                    <measurement group_id="O3" value="19.33"/>
                    <measurement group_id="O4" value="27.79"/>
                    <measurement group_id="O5" value="9.4"/>
                    <measurement group_id="O6" value="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.61"/>
                    <measurement group_id="O2" value="15.18"/>
                    <measurement group_id="O4" value="21.71"/>
                    <measurement group_id="O5" value="8.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.44"/>
                    <measurement group_id="O2" value="20.01"/>
                    <measurement group_id="O3" value="11.37"/>
                    <measurement group_id="O4" value="15.71"/>
                    <measurement group_id="O6" value="6.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Free Testosterone - Week 16</title>
        <description>Measure of Free Testosterone</description>
        <time_frame>Week 16</time_frame>
        <population>FT measured at the end of Week 16
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 22 in clomiphene-placebo-anastrazole arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Free Testosterone - Week 16</title>
          <description>Measure of Free Testosterone</description>
          <population>FT measured at the end of Week 16
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 22 in clomiphene-placebo-anastrazole arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.16"/>
                    <measurement group_id="O2" value="16.37"/>
                    <measurement group_id="O3" value="12.27"/>
                    <measurement group_id="O4" value="12.67"/>
                    <measurement group_id="O5" value="19.21"/>
                    <measurement group_id="O6" value="17.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.83"/>
                    <measurement group_id="O2" value="5.7"/>
                    <measurement group_id="O3" value="14.7"/>
                    <measurement group_id="O4" value="9.63"/>
                    <measurement group_id="O5" value="14.57"/>
                    <measurement group_id="O6" value="13.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.17"/>
                    <measurement group_id="O2" value="5.98"/>
                    <measurement group_id="O4" value="6.63"/>
                    <measurement group_id="O5" value="16.38"/>
                    <measurement group_id="O6" value="7.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.98"/>
                    <measurement group_id="O2" value="9.46"/>
                    <measurement group_id="O3" value="11.22"/>
                    <measurement group_id="O6" value="11.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Free Testosterone - Week 24</title>
        <description>Measure of Free Testosterone</description>
        <time_frame>Week 24</time_frame>
        <population>FT measured at the end of Week 24 Data not collected for patient 8 in APC arm Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm No data collected pt 24 in PAC arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Free Testosterone - Week 24</title>
          <description>Measure of Free Testosterone</description>
          <population>FT measured at the end of Week 24 Data not collected for patient 8 in APC arm Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm No data collected pt 24 in PAC arm</population>
          <units>ng/dl</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.51"/>
                    <measurement group_id="O2" value="19.35"/>
                    <measurement group_id="O3" value="6.25"/>
                    <measurement group_id="O4" value="11.28"/>
                    <measurement group_id="O5" value="8.65"/>
                    <measurement group_id="O6" value="19.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.11"/>
                    <measurement group_id="O3" value="11.09"/>
                    <measurement group_id="O4" value="17.89"/>
                    <measurement group_id="O5" value="11.63"/>
                    <measurement group_id="O6" value="25.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.82"/>
                    <measurement group_id="O2" value="13.74"/>
                    <measurement group_id="O4" value="18.19"/>
                    <measurement group_id="O5" value="15.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.82"/>
                    <measurement group_id="O2" value="13.54"/>
                    <measurement group_id="O3" value="6.11"/>
                    <measurement group_id="O4" value="16.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estradiol - Screen</title>
        <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24</description>
        <time_frame>Baseline</time_frame>
        <population>Estradiol measurement at initial encounter
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol - Screen</title>
          <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24</description>
          <population>Estradiol measurement at initial encounter
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>pg/mL</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6"/>
                    <measurement group_id="O2" value="8.1"/>
                    <measurement group_id="O3" value="9.6"/>
                    <measurement group_id="O4" value="13.5"/>
                    <measurement group_id="O5" value="15.9"/>
                    <measurement group_id="O6" value="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="19.3"/>
                    <measurement group_id="O3" value="21.3"/>
                    <measurement group_id="O4" value="11.4"/>
                    <measurement group_id="O5" value="18.6"/>
                    <measurement group_id="O6" value="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3"/>
                    <measurement group_id="O2" value="20.1"/>
                    <measurement group_id="O3" value="16.2"/>
                    <measurement group_id="O4" value="14.1"/>
                    <measurement group_id="O5" value="15.9"/>
                    <measurement group_id="O6" value="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5"/>
                    <measurement group_id="O2" value="15.5"/>
                    <measurement group_id="O3" value="26.6"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O6" value="26.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estradiol - Week 8</title>
        <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
        <time_frame>Week 8</time_frame>
        <population>Estradiol measurement at the end of Week 8
Data was not collected for patient 2 in anastrazole-placebo-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol - Week 8</title>
          <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
          <population>Estradiol measurement at the end of Week 8
Data was not collected for patient 2 in anastrazole-placebo-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>pg/mL</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2"/>
                    <measurement group_id="O3" value="49.8"/>
                    <measurement group_id="O4" value="94.5"/>
                    <measurement group_id="O5" value="20.8"/>
                    <measurement group_id="O6" value="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="15.1"/>
                    <measurement group_id="O3" value="70.1"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="18.5"/>
                    <measurement group_id="O6" value="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.7"/>
                    <measurement group_id="O2" value="4.9"/>
                    <measurement group_id="O3" value="25.1"/>
                    <measurement group_id="O4" value="33.5"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4"/>
                    <measurement group_id="O2" value="10.7"/>
                    <measurement group_id="O3" value="51.7"/>
                    <measurement group_id="O4" value="39.1"/>
                    <measurement group_id="O6" value="27.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estradiol - Week 16</title>
        <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
        <time_frame>Week 16</time_frame>
        <population>Estradiol measurement at the end of Week 16 Data was not collected for patient 2 in anastrazole-placebo-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol - Week 16</title>
          <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
          <population>Estradiol measurement at the end of Week 16 Data was not collected for patient 2 in anastrazole-placebo-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>pg/mL</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.5"/>
                    <measurement group_id="O3" value="8.9"/>
                    <measurement group_id="O4" value="17.9"/>
                    <measurement group_id="O5" value="56.9"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1"/>
                    <measurement group_id="O2" value="21.6"/>
                    <measurement group_id="O3" value="12.8"/>
                    <measurement group_id="O4" value="14.4"/>
                    <measurement group_id="O5" value="28.2"/>
                    <measurement group_id="O6" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.1"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="23.8"/>
                    <measurement group_id="O4" value="13.1"/>
                    <measurement group_id="O5" value="37"/>
                    <measurement group_id="O6" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.5"/>
                    <measurement group_id="O2" value="28.3"/>
                    <measurement group_id="O3" value="14.8"/>
                    <measurement group_id="O4" value="15.9"/>
                    <measurement group_id="O6" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estradiol - Week 24</title>
        <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
        <time_frame>Week 24</time_frame>
        <population>Estradiol measurement at the end of Week 24
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol - Week 24</title>
          <description>Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was &lt;5</description>
          <population>Estradiol measurement at the end of Week 24
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
          <units>pg/mL</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5"/>
                    <measurement group_id="O2" value="43.9"/>
                    <measurement group_id="O3" value="16.2"/>
                    <measurement group_id="O4" value="9.5"/>
                    <measurement group_id="O5" value="18.1"/>
                    <measurement group_id="O6" value="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5"/>
                    <measurement group_id="O2" value="49.1"/>
                    <measurement group_id="O3" value="6.6"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="11.6"/>
                    <measurement group_id="O6" value="85.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.5"/>
                    <measurement group_id="O2" value="36.4"/>
                    <measurement group_id="O4" value="9.2"/>
                    <measurement group_id="O5" value="4.9"/>
                    <measurement group_id="O6" value="29.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.2"/>
                    <measurement group_id="O2" value="39.4"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SHBG - Screen</title>
        <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
        <time_frame>Baseline</time_frame>
        <population>SHBG measured at initial encounter
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SHBG - Screen</title>
          <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
          <population>SHBG measured at initial encounter
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>nmol/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.9"/>
                    <measurement group_id="O2" value="35.2"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="31.7"/>
                    <measurement group_id="O5" value="26.2"/>
                    <measurement group_id="O6" value="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.7"/>
                    <measurement group_id="O2" value="12.6"/>
                    <measurement group_id="O3" value="23.5"/>
                    <measurement group_id="O4" value="26.4"/>
                    <measurement group_id="O5" value="20.9"/>
                    <measurement group_id="O6" value="26.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5"/>
                    <measurement group_id="O2" value="17.5"/>
                    <measurement group_id="O3" value="21.4"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="16.9"/>
                    <measurement group_id="O6" value="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.6"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="35.5"/>
                    <measurement group_id="O4" value="11.6"/>
                    <measurement group_id="O6" value="30.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SHBG - Week 8</title>
        <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
        <time_frame>Week 8</time_frame>
        <population>SHBG measured at week 8
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SHBG - Week 8</title>
          <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
          <population>SHBG measured at week 8
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>nmol/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="38.2"/>
                    <measurement group_id="O3" value="18.4"/>
                    <measurement group_id="O4" value="29.8"/>
                    <measurement group_id="O5" value="23.9"/>
                    <measurement group_id="O6" value="21.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.4"/>
                    <measurement group_id="O2" value="12.7"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="27.2"/>
                    <measurement group_id="O5" value="24.1"/>
                    <measurement group_id="O6" value="25.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9"/>
                    <measurement group_id="O2" value="16.1"/>
                    <measurement group_id="O3" value="21.6"/>
                    <measurement group_id="O4" value="30.9"/>
                    <measurement group_id="O5" value="14.3"/>
                    <measurement group_id="O6" value="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.1"/>
                    <measurement group_id="O2" value="20.1"/>
                    <measurement group_id="O3" value="42.7"/>
                    <measurement group_id="O4" value="20.9"/>
                    <measurement group_id="O6" value="30.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SHBG - Week 16</title>
        <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
        <time_frame>Week 16</time_frame>
        <population>SHBG measured at week 16
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SHBG - Week 16</title>
          <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
          <population>SHBG measured at week 16
Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm</population>
          <units>nmol/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.3"/>
                    <measurement group_id="O2" value="35.5"/>
                    <measurement group_id="O3" value="13.8"/>
                    <measurement group_id="O4" value="16.4"/>
                    <measurement group_id="O5" value="33.3"/>
                    <measurement group_id="O6" value="17.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.7"/>
                    <measurement group_id="O2" value="15.3"/>
                    <measurement group_id="O3" value="26.6"/>
                    <measurement group_id="O4" value="31"/>
                    <measurement group_id="O5" value="16.7"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.8"/>
                    <measurement group_id="O2" value="17.2"/>
                    <measurement group_id="O3" value="14.2"/>
                    <measurement group_id="O4" value="22.8"/>
                    <measurement group_id="O5" value="17.2"/>
                    <measurement group_id="O6" value="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.3"/>
                    <measurement group_id="O2" value="24.8"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="13.9"/>
                    <measurement group_id="O6" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SHBG - Week 24</title>
        <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
        <time_frame>Week 24</time_frame>
        <population>SHBG measured at week 24
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SHBG - Week 24</title>
          <description>Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24</description>
          <population>SHBG measured at week 24
Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm</population>
          <units>nmol/L</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6"/>
                    <measurement group_id="O2" value="41.8"/>
                    <measurement group_id="O3" value="15.1"/>
                    <measurement group_id="O4" value="25.2"/>
                    <measurement group_id="O5" value="29.7"/>
                    <measurement group_id="O6" value="23.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.8"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="24.4"/>
                    <measurement group_id="O4" value="25.3"/>
                    <measurement group_id="O5" value="13.8"/>
                    <measurement group_id="O6" value="34.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="21.7"/>
                    <measurement group_id="O4" value="20.1"/>
                    <measurement group_id="O5" value="17.3"/>
                    <measurement group_id="O6" value="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.2"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="33.8"/>
                    <measurement group_id="O4" value="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SEP #1-3 Cumulative - Screen</title>
        <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
        <time_frame>Baseline</time_frame>
        <population>SEP measured at the initial encounter
Baseline SPEP was not measured for participants 1-24
Table included for completeness</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SEP #1-3 Cumulative - Screen</title>
          <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
          <population>SEP measured at the initial encounter
Baseline SPEP was not measured for participants 1-24
Table included for completeness</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
            </class>
            <class>
              <title>Patients 7-12</title>
            </class>
            <class>
              <title>Patients 13-18</title>
            </class>
            <class>
              <title>Patients 19-24</title>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SEP #1-3 Cumulative - Week 8</title>
        <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
        <time_frame>Week 8</time_frame>
        <population>SEP measured at the end of week 8
data not collected for pt 11,17 in PCA arm data not collected for pt 13 in ACP arm data not collected for pt 15 in CAP arm data not collected for pt 22 in CPA arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SEP #1-3 Cumulative - Week 8</title>
          <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
          <population>SEP measured at the end of week 8
data not collected for pt 11,17 in PCA arm data not collected for pt 13 in ACP arm data not collected for pt 15 in CAP arm data not collected for pt 22 in CPA arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="2"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SEP #1-3 Cumulative - Week 16</title>
        <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
        <time_frame>Week 16</time_frame>
        <population>SEP measured at the end of week 16
data not collected for pt 3,15 in CAP arm data not collected for pt 5,11,23 in PCA arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SEP #1-3 Cumulative - Week 16</title>
          <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
          <population>SEP measured at the end of week 16
data not collected for pt 3,15 in CAP arm data not collected for pt 5,11,23 in PCA arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SEP #1-3 Cumulative - Week 24</title>
        <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
        <time_frame>Week 24</time_frame>
        <population>SEP measured at the end of week 24 data not collected for pt 1,13 in ACP arm data not collected for pt 3, 15 in CAP arm data not collected for pt 22 in CPA arm data not collected for pt 11,23 PCA arm</population>
        <group_list>
          <group group_id="O1">
            <title>Anastrazole-clomiphene-placebo</title>
            <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O2">
            <title>Anastrazole-placebo-clomiphene</title>
            <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O3">
            <title>Clomiphene-anastrazole-placebo</title>
            <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O4">
            <title>Clomiphene-placebo-anastrazole</title>
            <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O5">
            <title>Placebo-clomiphene-anastrazole</title>
            <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
          <group group_id="O6">
            <title>Placebo-anastrazole-clomiphene</title>
            <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
          </group>
        </group_list>
        <measure>
          <title>SEP #1-3 Cumulative - Week 24</title>
          <description>Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.
0-3: cumulative score from SEP questions 1, 2, and 3
Higher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0</description>
          <population>SEP measured at the end of week 24 data not collected for pt 1,13 in ACP arm data not collected for pt 3, 15 in CAP arm data not collected for pt 22 in CPA arm data not collected for pt 11,23 PCA arm</population>
          <units>score on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="2"/>
                <count group_id="O6" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients 1-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 7-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 13-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients 19-24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected after the first dose of medication and at the end of week 8, week 16, and week 24 at a participant and provider meeting.</time_frame>
      <desc>The 6 arms are comprised of certain orders of drug administration. To maintain the integrity of this order, AE have been listed as part of the arm it belongs to. Details regarding when the AE occurred in relation to the drug being administered at that point in time during the arm is listed at the bottom of the table.</desc>
      <group_list>
        <group group_id="E1">
          <title>Anastrazole-clomiphene-placebo</title>
          <description>anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="E2">
          <title>Anastrazole-placebo-clomiphene</title>
          <description>anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="E3">
          <title>Clomiphene-anastrazole-placebo</title>
          <description>clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="E4">
          <title>Clomiphene-placebo-anastrazole</title>
          <description>clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="E5">
          <title>Placebo-clomiphene-anastrazole</title>
          <description>placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
        <group group_id="E6">
          <title>Placebo-anastrazole-clomiphene</title>
          <description>placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks
Anastrozole 1mg
Clomiphene Citrate 25mg
Placebo - Cap</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Lyme Disease</sub_title>
                <description>AE occured during placebo</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <description>AE occured during placebo.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Weight Gain</sub_title>
                <description>AE occured during anastrazole</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Decreased Libido</sub_title>
                <description>AE occured during clomiphene</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bloated</sub_title>
                <description>AE occured during clomiphene</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>AE occured during anastrazole in both trial arms indicated.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Nasal Septal Deviation</sub_title>
                <description>Nasal Septal deviation AE occured during clomiphene.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <description>AE occured during anastrazole in the trial arms indicated.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <description>AE occured during clomiphene of both trial arms indicated</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper Respiratory Infection (URI)</sub_title>
                <description>AE occured during placebo.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Ringworm</sub_title>
                <description>Ringworm AE occured during clomiphene.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteopenia</sub_title>
                <description>Osteopenia AE occurred during anastrazole.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Rib Pain</sub_title>
                <description>AE occured during anastrazole.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Left Shoulder Pain</sub_title>
                <description>Left shoulder AE occured during placebo.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Right Big Toe Pain</sub_title>
                <description>AE occured during anastrazole</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <description>AE occured during clomiphene</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic Maxillary Sinusitis</sub_title>
                <description>AE occured during clomiphene</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Charles Welliver</name_or_title>
      <organization>Albany Medical Center</organization>
      <phone>518-262-3341</phone>
      <email>wellivr@amc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

